PP2A Inhibition Causes Synthetic Lethality in BRCA2-Mutated Prostate Cancer Models via Reactivating Spindle Assembly Checkpoint

One of the paradoxes concerning BRCA2 is the fact that its inactivation affects genetic stability and is deleterious for cellular and organismal survival, while BRCA2-mutated cancer cells adapt to this detriment and malignantly proliferate.